FDA Offers Updated on Non-Tobacco Nicotine Product Review

Synthetic Nicotine | Nicotine Pouches

The U.S. Food and Drug Administration (FDA) has offered an update on its progress reviewing nearly one million applications for non-tobacco nicotine (NTN) products. According to the FDA, it has completed its initial review of 95 percent of non-tobacco nicotine product applications and has issued over 60 warning letters to manufacturers as a result of its review.

As of Oct. 7, the FDA has issued Refuse to Accept (RTA) letters for more than 889,000 products in applications that it feels does not meet the criteria for the acceptance. The FDA also accepted over 1,600 applications which it revealed mostly consisted of e-cigarette and e-liquid products.

The FDA has issued over 60 warning letters to manufacturers of NTN products, including one recently to Puff Bar, a popular e-cigarette brand among youth [read more here]. Retailers have also received warning letters related to NTN products.

“The manufacturer warning letters include those for products for which an application had been submitted but where the agency has taken a negative action, such as a Refuse to Accept Letter. FDA has also issued over 300 warning letters to retailers for violations in relation to their sale of NTN products to underage purchasers, and imposed civil money penalties against two retailers for sales of NTN products to underage purchasers,” the company wrote in a recent update issued via Twitter.